TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›HBAN
HBAN logo

HBAN

HUNTINGTON BANCSHARES INC /MD/

Next earnings Jul 23, 2026 · consensus $0.37 EPS, $2.90B rev

Last earnings +0.1% on 2026-04-23

Buy
$17.86
▲ +0.22%
$17.86▲ +11.62%
over 1Y
L $14.74H $18.91
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.2%
1W-0.2%
1M+11.0%
3M+14.1%
YTD+4.1%
1Y+11.6%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Buy
Quality
B
Valuation
Undervalued
Filings
Clean
Buy
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 24 analysts
Buy

Cheap, well-capitalized regional bank compounding earnings double-digits at 12.9x P/E with a fortress balance sheet and a Cadence-fueled growth runway.

Diluted EPS $1.39 · FY2025

The read

Quality fundamentals and an attractive price line up (~94% below fair value) — the rarer case where both the business and the entry look good.

Huntington screens as a high-quality regional bank trading at a discount to its own earnings power. FY2025 net income of $2.21B (+14.0% YoY) on diluted EPS of $1.39 (+13.9%) translates to a 12.9x P/E — below the long-run average for solid super-regional banks, especially one growing this fast. Stockholders' equity jumped 23.3% to $24.3B while total assets grew 10.2% to $225B, indicating capital is building faster than the balance sheet — a healthy setup for a bank holding company. Operating cash flow of $2.48B (+35.2%) comfortably covers the $908M dividend, which gives the stock a meaningful, well-covered yield at $17.90.

The 10-K's Note 3 explicitly flags Business Combinations and the glossary names 'Cadence' (Cadence Bank), confirming the recently closed acquisition that the 39.6% jump in shares outstanding paid for. That dilution is real but the earnings line absorbed it and EPS still grew double-digits — meaning the deal is already accretive on a per-share basis, not just on aggregate. Coupled with the 22.5% rise in D&A and 86.7% surge in capex, Huntington is clearly in invest-mode (tech, branches, integration) yet still throwing off cash. The 10-K's heavy emphasis on Credit Risk, Market Risk, Liquidity Risk and the LCR/HQLA framework signals a disciplined risk culture — appropriate given the 8.25x liabilities/equity ratio that is normal for a bank but leaves no margin for sloppy underwriting.

Is HBAN a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Bull call spread (wide)~90d expiry
  • Long call 18 @ ~0.87 est
  • Short call 20.5 @ ~0.16 est
debit $71max +$179max −$71BE 18.71

High-conviction BUY: a wider spread keeps more of the upside while the short call still cuts cost and decay.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$1.11B$1.32B$1.40B$1.47B$1.56B
Gross profit—————
Operating income—————
Net income$1.29B$2.24B$1.95B$1.94B$2.21B
Diluted EPS$0.90$1.45$1.24$1.22$1.39
Net margin116.4%169.8%139.4%132.2%141.5%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF16.3
PEG (trailing)0.92
Earnings yield6.1%
FCF yield6.1%

Quality & risk

ROIC (est.)—
Free cash flow$2.21B
Total debt$18.5B
Net cash-$4.99B
Piotroski F-Score5/7

Capital returns

Buyback yield0.0%
Dividend yield (est.)2.5%
Shareholder yield2.5%
Shares Δ YoY+39.6%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has been improving.
  1. 8-K Other event2026-06-25

    Other event disclosure with exhibits; no material financial impact signaled.

  2. 8-K Reg FD disclosure2026-06-08

    Reg FD investor/conference materials furnished; informational update only.

  3. 8-K Reg FD disclosure2026-05-27

    Reg FD presentation materials furnished; routine investor communication.

  4. 10-Q Quarterly report2026-04-30

    Q1'26 10-Q confirms balance-sheet growth; assets $225B, equity +23% YoY.

  5. 8-K Shareholder vote2026-04-24

    Annual meeting vote results; directors elected, routine governance items passed.

  6. 8-K Other event2026-04-23

    Q1 earnings release; FY momentum continues with EPS and NII trending higher.

  7. 8-K Earnings results2026-04-23

    Q1 earnings release; FY momentum continues with EPS and NII trending higher.

  8. 8-K/A Amended 8-K2026-04-15

    Amendment to prior 8-K; supplemental info, no new material change.

  9. DEF 14A Proxy statement2026-03-12

    Proxy for annual meeting; standard director/comp/auditor proposals.

Recent filings

all on EDGAR ↗
4Period ending 2026-06-252026-06-26open ↗11-KPeriod ending 2025-12-312026-06-25open ↗8-KPeriod ending 2026-06-252026-06-25open ↗144Filing2026-06-25open ↗4Period ending 2026-06-122026-06-16open ↗144Filing2026-06-12open ↗8-KPeriod ending 2026-06-082026-06-08open ↗4Period ending 2026-06-022026-06-04open ↗4Period ending 2026-06-012026-06-03open ↗144Filing2026-06-01open ↗8-KPeriod ending 2026-05-272026-05-27open ↗13F-HRPeriod ending 2026-03-312026-05-15open ↗

Quality score

B
ValueGrowthProfitHealthMom.
ValueC-
GrowthB+
ProfitabilityA-
Financial healthA-
MomentumB
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✗Return on equity above 15%
  • ✓P/E below 25

Fair value est.

$34.71

Undervalued +94% vs price

cheapfair valueexpensive

Modified Graham: EPS $1.39 × (8.5 + 1.5 × 10.2% growth) × 1.05 quality = 25.0× multiple. An estimate, not a price target.

14.7452-week18.91
Revenue
$1.56B
+6.4% YoY
Net margin
141.5%
ROE
9.1%
P/E
12.8

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$1.56B+6.4%
Net income$2.21B+14.0%
Diluted EPS$1.39+13.9%
Cash & equivalents$13.5B+5.0%
Total assets$225B+10.2%
Total liabilities$201B+8.8%
Stockholders' equity$24.3B+23.3%
L/E: 8.25x

Frequently asked

Is HUNTINGTON BANCSHARES INC /MD/ (HBAN) a buy?
HBAN currently carries a Buy rating with 4/5 conviction, derived from its latest SEC filings. Cheap, well-capitalized regional bank compounding earnings double-digits at 12.9x P/E with a fortress balance sheet and a Cadence-fueled growth runway.
What is HBAN's fair value?
A Modified-Graham model based on HBAN's SEC fundamentals estimates a fair value of about $34.71. It is an estimate from reported earnings, not a price target.
Is HBAN overvalued or undervalued?
Against a Modified-Graham fair-value estimate, HBAN currently appears undervalued relative to its SEC-grounded earnings power.
What is HUNTINGTON BANCSHARES INC /MD/'s quality score?
HBAN scores 72.5973173186292/100 (grade B) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000049196, latest 10-Q filed 2026-04-30) · EODHD · Proprietary analysis · as of 6/26/2026, 1:38:54 AM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 9:38 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 4 open-market buys · 3 sales

2026-06-25
Hingst Marcy C
SEVP and General Counsel
Sell10.6K @ $18.00$190K
2026-06-12
ROLLINS JAMES D III
Director
Sell224K @ $17.35$3.88M
2026-06-04
ROLLINS JAMES D III
Director
Buy4.80K @ $20.30$97.4K
2026-06-03
ROLLINS JAMES D III
Director
Buy873.00 @ $16.46$14.4K
2026-06-03
ROLLINS JAMES D III
Director
Buy5.20K @ $20.35$106K
2026-06-02
ROLLINS JAMES D III
Director
Buy11.1K @ $16.50$184K
2026-06-01
Kleinman Scott D
Senior Exec. V.P.
Sell19.4K @ $16.20$315K
2026-05-06
Pohmer Sarah E
SEVP-CHRO
Tax19.9K @ $16.64$331K
2026-05-01
Sit Roger J
Director
Award9.32K
2026-05-01
Shea Teresa H
Director
Award9.32K
2026-05-01
Rodriguez Alice L
Director
Award9.32K

Held by tracked funds

Form 13F · SEC · quarterly
Millennium ManagementIzzy Englander25.9M sh$406M
Point72 Asset ManagementSteve Cohen7.40M sh$116M
Renaissance Technologies5.19M sh$81.3M
D. E. Shaw & Co.5.06M sh$79.2M
Fisher Asset ManagementKen Fisher3.28M sh$51.3M

As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →

Dividends

Quarterly
Yield (TTM)
3.5%
Annual / share
$0.62
Last ex-date
2026-06-17
Last amount
$0.16
ex 2026-06-17paid 2026-07-01$0.16
ex 2026-03-18paid 2026-04-01$0.16
ex 2025-12-18paid 2026-01-02$0.16
ex 2025-09-17paid 2025-10-01$0.16
ex 2025-06-17paid 2025-07-01$0.16
ex 2025-03-18paid 2025-04-01$0.16

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-04-23Miss -23.5% est▼ -3.11%8-K ↗
2026-01-22Miss -0.7% est▼ -0.23%8-K ↗
2025-10-20Beat +7.4% est▲ +3.68%8-K ↗
2025-10-17Beat +7.4% est▼ -0.64%8-K ↗
2025-07-18Miss -2.7% est▼ -2.00%8-K ↗
2025-07-14Miss -2.7% est▼ -3.30%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2025-05-08Rob BresnahanSell$1.00K–$15.0KPTR ↗
2018-08-20John RutherfordBuy$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Vs Financials peers

compare →

185 tracked peers · median

TENK Score73 vs 73
Revenue growth6.4% vs 7.7%
Net margin141.5% vs 21.3%
Return on equity9.1% vs 12.3%
P/E12.8 vs 15.4
Peers
WTMJHGRNRALLPRIPGROMFSLM